This HTML5 document contains 78 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n18https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
n13http://mlbplayers.mlb.com/pa/pdf/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Major_League_Baseball_drug_policy
rdf:type
yago:Substance100020090 yago:Matter100020827 yago:WikicatDrugsInSportInTheUnitedStates yago:Agent114778436 yago:Drug103247620 owl:Thing yago:CausalAgent100007347 yago:PhysicalEntity100001930
rdfs:label
Major League Baseball drug policy
rdfs:comment
Major League Baseball's drug policy—the Joint Drug Prevention and Treatment Program—was established by agreement between the MLB Players Association and the Office of the Commissioner of Baseball. The goal was to deter and end the use of banned substances, including anabolic steroids and other illegal drugs, and to "provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application" of the policy itself. The Joint Drug Prevention and Treatment Program was adopted in the Spring of 2006.
rdfs:seeAlso
dbr:List_of_Major_League_Baseball_players_suspended_for_performance-enhancing_drugs
dcterms:subject
dbc:Drugs_in_sport_in_the_United_States dbc:Doping_in_baseball dbc:Major_League_Baseball_controversies dbc:Major_League_Baseball_labor_relations
dbo:wikiPageID
2939912
dbo:wikiPageRevisionID
1122283555
dbo:wikiPageWikiLink
dbr:Anabolic_steroids dbr:Lysergic_acid_diethylamide dbr:Nandrolone dbr:Nolo_contendere dbr:List_of_Major_League_Baseball_players_suspended_for_performance-enhancing_drugs dbr:Commissioner_of_Baseball dbr:Cannabinoids dbr:Major_League_Baseball dbr:Controlled_Substances_Act dbr:Ban_(law) dbr:Cannabinoid dbc:Drugs_in_sport_in_the_United_States dbr:Medical_examinations dbr:Tetrahydrocannabinol dbc:Doping_in_baseball dbr:Illegal_drug_trade dbr:List_of_banned_substances_in_baseball dbr:MDMA dbr:Oxycodone dbc:Major_League_Baseball_controversies dbr:Synthetic_cannabis dbr:Testosterone_(medication) dbr:Phencyclidine dbr:Codeine dbr:Gamma-Hydroxybutyric_acid dbr:Drugs_of_abuse dbr:United_States_Congress dbr:Major_League_Baseball_Players_Association dbr:Heroin dbr:Progressive_discipline dbr:Toxicology dbr:Marijuana dbr:Baseball_Commissioner dbc:Major_League_Baseball_labor_relations dbr:Jenrry_Mejía dbr:Reasonable_cause dbr:Hashish dbr:Drug_of_abuse dbr:Cocaine dbr:Morphine dbr:Opiate dbr:Drug dbr:Human_growth_hormone
dbo:wikiPageExternalLink
n13:jda.pdf
owl:sameAs
yago-res:Major_League_Baseball_drug_policy freebase:m.08f0gs wikidata:Q6738162 n18:4qcc8
dbp:wikiPageUsesTemplate
dbt:More_footnotes dbt:See_also dbt:Multiple_issues dbt:Primary_sources dbt:Refimprove dbt:Main dbt:Reflist dbt:One_source dbt:Doping_in_baseball
dbo:abstract
Major League Baseball's drug policy—the Joint Drug Prevention and Treatment Program—was established by agreement between the MLB Players Association and the Office of the Commissioner of Baseball. The goal was to deter and end the use of banned substances, including anabolic steroids and other illegal drugs, and to "provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application" of the policy itself. The Joint Drug Prevention and Treatment Program was adopted in the Spring of 2006. While the Health Policy Advisory Committee (HPAC) can make recommendations to the Office of the Commissioner regarding punishment, it has no power to discipline players for violations of the drug policy, except to place them in the appropriate treatment programs. Such authority belongs to the Office of the Commissioner.
prov:wasDerivedFrom
wikipedia-en:Major_League_Baseball_drug_policy?oldid=1122283555&ns=0
dbo:wikiPageLength
12693
foaf:isPrimaryTopicOf
wikipedia-en:Major_League_Baseball_drug_policy